Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 118.7325
1.04 %
$ 11.8 B
Market Cap
36.09
P/E
Price Target
Average
36.13%
Revenue Forecast
Estimate
15.89%
EBIT
Estimate
12.87%
Net Income
Estimate
40.14%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Neurocrine Biosciences, Inc.
Wall Street analysts predict an average 1-year price target for NBIX of $162 , with forecasts ranging from
a
low of
$121 to a high of $200 .
NBIX Lowest Price Target
Wall Street Target
121 USD
1.91%
NBIX Average Price Target
Wall Street Target
162 USD
36.13%
NBIX Highest Price Target
Wall Street Target
200 USD
68.45%
REVENUE FORECAST
Revenue Forecast Chart NBIX
EBIT FORECAST
EBIT Forecast Chart NBIX
NET INCOME FORECAST
Net Income Chart NBIX